• Hyperphosphatemia

Velphoro Generic Name & Formulations

General Description

Sucroferric oxyhydroxide 500mg; chew tabs.

Pharmacological Class

Phosphate binder.

How Supplied

Chew tabs—90

Velphoro Indications


For control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Velphoro Dosage and Administration


Chew, do not swallow whole. Take with meals. Initially 500mg 3 times daily; monitor serum phosphorus levels and titrate dose in decrements or increments of 500mg/day as needed until acceptable serum phosphorus level reached. May titrate as often as weekly.


Not established.

Velphoro Contraindications

Not Applicable

Velphoro Boxed Warnings

Not Applicable

Velphoro Warnings/Precautions


GI, hepatic, or iron accumulation disorders; monitor effect and iron homeostasis.

Velphoro Pharmacokinetics

See Literature

Velphoro Interactions


Separate dosing of doxycycline, acetylsalicylic acid, cephalexin by ≥1hr before Velphoro; levothyroxine by ≥4hrs before. Concomitant drugs with narrow therapeutic index; monitor.

Velphoro Adverse Reactions

Adverse Reactions

Discolored feces, diarrhea, nausea.

Velphoro Clinical Trials

See Literature

Velphoro Note

Not Applicable

Velphoro Patient Counseling

See Literature